IDEAYA Biosciences (IDYA) Accumulated Expenses (2018 - 2026)
IDEAYA Biosciences (IDYA) posted Accumulated Expenses of $50.98 million for Q2 2026, up 35.0% from $37.75 million a year earlier and up 16.5% from the prior quarter.
IDEAYA Biosciences (IDYA) Accumulated Expenses (2018 - 2026) Analysis & Trends
At the end of FY2025, IDEAYA Biosciences' Accumulated Expenses came in at $40.89 million, up 34.7% from FY2024.
- Annual Accumulated Expenses has increased for seven consecutive years, with a five-year compound annual growth rate of 36.9% (FY2020 to FY2025).
- In prior years, IDEAYA Biosciences' Accumulated Expenses was $30.35 million in FY2024 (+61.8%), $18.76 million in FY2023 (+10.3%), $17 million in FY2022 (+38.0%) and $12.32 million in FY2021 (+44.7%).
- The Q2 2026 figure stands as the highest quarterly Accumulated Expenses in data going back to Q4 2018.
- On a year-over-year basis, Accumulated Expenses has increased in each of the last 11 quarters, with growth averaging 55.3% over the last eight quarters.
- The strongest year-over-year quarter for Accumulated Expenses in the past five years was Q1 2025, with growth of 87.8%; the weakest was Q2 2023, with a decline of 9.5%.
- According to Business Quant data, Accumulated Expenses for the three prior quarters was $43.75 million (Q1 2026), $40.89 million (Q4 2025) and $45.26 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn |
| 10 | IDEAYA Biosciences | 3.70 Bn | 776.31 Mn | - |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 50.98 Mn |
| Mar 31, 2026 | 43.75 Mn |
| Dec 31, 2025 | 40.89 Mn |
| Sep 30, 2025 | 45.26 Mn |
| Jun 30, 2025 | 37.75 Mn |
| Mar 31, 2025 | 32.91 Mn |
| Dec 31, 2024 | 30.35 Mn |
| Sep 30, 2024 | 28.09 Mn |
| Jun 30, 2024 | 24.25 Mn |
| Mar 31, 2024 | 17.52 Mn |
| Dec 31, 2023 | 18.76 Mn |
| Sep 30, 2023 | 16.19 Mn |
| Jun 30, 2023 | 14.69 Mn |
| Mar 31, 2023 | 17.27 Mn |
| Dec 31, 2022 | 17.00 Mn |
| Sep 30, 2022 | 16.99 Mn |
| Jun 30, 2022 | 16.23 Mn |
| Mar 31, 2022 | 12.63 Mn |
| Dec 31, 2021 | 12.32 Mn |
| Sep 30, 2021 | 11.89 Mn |
IDEAYA Biosciences Accumulated Expenses API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IDYA&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "accumulated-expenses", "ticker": "IDYA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=IDYA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();